Why Sarepta Therapeutics, Rentrak, and Prosensa Are Today's 3 Best Stocks
Poor earnings from Best Buy drag down the S&P 500, while Sarepta Therapeutics, Rentrak, and Prosensa all soar by at least 24%!
Will Sarepta Therapeutics Benefit From GlaxoSmithKline's Exit?
Glaxo's out of a drug partnership for a rare condition also targeted by a troubled drug from Sarepta. How will the exit impact Sarepta's future?
GSK Leaves Prosensa Hanging
GlaxoSmithKline hands back rights to DMD program to Prosensa, which could affect rival Sarepta Therapeutics.